5NIU
Structure of human Programmed cell death 1 ligand 1 (PD-L1) with low molecular mass inhibitor
Summary for 5NIU
Entry DOI | 10.2210/pdb5niu/pdb |
Descriptor | Programmed cell death 1 ligand 1, (2~{R})-2-[[2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methyl-phenyl]methoxy]-5-methyl-phenyl]methylamino]-3-oxidanyl-propanoic acid, 1,2-ETHANEDIOL, ... (4 entities in total) |
Functional Keywords | pd-l1, pd-1, immune checkpoint, immune system |
Biological source | Homo sapiens (Human) |
Cellular location | Isoform 1: Cell membrane ; Single-pass type I membrane protein . Isoform 2: Endomembrane system ; Single-pass type I membrane protein : Q9NZQ7 |
Total number of polymer chains | 4 |
Total formula weight | 60028.48 |
Authors | Zak, K.M.,Grudnik, P.,Skalniak, L.,Dubin, G.,Holak, T.A. (deposition date: 2017-03-27, release date: 2017-12-06, Last modification date: 2024-01-17) |
Primary citation | Skalniak, L.,Zak, K.M.,Guzik, K.,Magiera, K.,Musielak, B.,Pachota, M.,Szelazek, B.,Kocik, J.,Grudnik, P.,Tomala, M.,Krzanik, S.,Pyrc, K.,Domling, A.,Dubin, G.,Holak, T.A. Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells. Oncotarget, 8:72167-72181, 2017 Cited by PubMed: 29069777DOI: 10.18632/oncotarget.20050 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.01 Å) |
Structure validation
Download full validation report